ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

GSK Gsk Plc

1,728.00
-0.50 (-0.03%)
Last Updated: 12:12:21
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50 -0.03% 1,728.00 1,727.50 1,728.50 1,739.50 1,724.50 1,733.00 1,116,102 12:12:21
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 14.47 71.29B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,728.50p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,739.50p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £71.29 billion. Gsk has a price to earnings ratio (PE ratio) of 14.47.

Gsk Share Discussion Threads

Showing 22451 to 22473 of 33150 messages
Chat Pages: Latest  906  905  904  903  902  901  900  899  898  897  896  895  Older
DateSubjectAuthorDiscuss
21/10/2020
09:48
SP is continuously dropping,my condolences to those who bought with the dividend money,if the oncoming results are slightly negative then the 12 pound GSK share price is imminent imo !
abdullla
21/10/2020
09:40
1300 it is then
amaretto1
20/10/2020
20:21
This reminds me of aviva, everyone keeps banging on about it being worth “ more “, and “ loading up on weakness “ bla bla, but they are both cxxp, buying stuff for dividends is a mugs game, buy growth, every time, this has become a shocker, I used to trade it now just short it when I can.
porsche1945
20/10/2020
19:47
A bid for the vaccine and pharma side of GSK would not be allowed,
certainly not at this time.

The only company that would be allowed to bid is AZN
and they do not need nor want GSK.

So for anyone looking to buy GSK in the hope of a bid,
It's very unlikely.

That does not stop occasional media speculation.

essentialinvestor
20/10/2020
18:12
Berenberg today did not help, we know revenue going to be down next Wednesday. All in the price.
montyhedge
20/10/2020
17:28
Lol. Broken recent support. Best move funds in readiness for another slug at 1300p. If it breaks that then I guess it'll get swallowed by an overseas investor/company for breakup. All imo. spud
spud
20/10/2020
17:25
Your main computer?, how many do you have ).
essentialinvestor
20/10/2020
17:20
Very definitely, ouch! 2.6m after the bell. I'm guessing a UT as I'm not near my main computer. spud
spud
20/10/2020
16:47
Looks that way, what's that 23% off their high.
montyhedge
20/10/2020
16:43
Downtrend still intact?.
essentialinvestor
20/10/2020
15:02
Berenberg saying 3rd quarter figures to lag behind, we all know that, surely that's why they are 1389p, has long has the 19p dividend ok.
montyhedge
20/10/2020
14:13
Now is the time for quality stock accumulation ready for when the Market regains it's ability to apply correct valuations. spud
spud
20/10/2020
13:46
Interesting.
montyhedge
20/10/2020
13:26
GSK having slipped down the BigPharma league table is a story in itself. Will it end up by getting truly broken up?

2 Swiss companies in the top 3 now. They were going to merge but are now too big to merge.

alphorn
20/10/2020
13:16
Ah, the inimitable Mr Dury ).
essentialinvestor
20/10/2020
13:14
Reasons to be cheerful, Part 2

The 'split' produces 2 leading companies to create one of the world’s leader in Consumer Healthcare, with scale and strong capabilities, powered by category leading brands and science based innovation

New competitive Pharmaceuticals and Vaccines company with R&D focused on science of the immune system, genetics and advanced technologies

New world-leading Consumer Healthcare company with category leading power brands and
science based innovation

tradermichael
20/10/2020
12:59
Reasons to be cheerful, Part 1:

Product pipeline:

6 new products with on going registration around the world

11 new products at Phase III

2 potential new products at Phase II/III

17 potential products at Phase II

15 potential products at Phase I

tradermichael
20/10/2020
12:44
Plenty of good GSK news.
tradermichael
20/10/2020
12:38
The share price is in a lull before third quarter 2020 results on Wednesday 28 October, 2020.
tradermichael
20/10/2020
12:01
On equity market opportunities I'm relatively optimistic for 2021.

We have an ugly few months ahead with COVID and potentially
some stock market downside/increase in volatility to first navigate.

Would hope by H2 2021 some semblance of normality to everyday life
will have returned.

essentialinvestor
20/10/2020
11:55
Hmmm, P1945 - things will get better!
tradermichael
20/10/2020
11:41
Just keeps sinking. Dividend cut imminent, weak drug pipeline, far too much debt ( the bio tech purchase Tesoro down the drain money 5.1b usd) and covid affecting prescriptions, things have really caught up with gsk and its years of cxxp management, the split will make zero difference to value, next stop for these about 12.50/80. Ftse 350 terminal, reflective of U.K. in general.
porsche1945
20/10/2020
11:27
Pfizer has already submitted one application for approval - Swissmedic said Pfizer submitted an application for the authorisation of a vaccine which is based on the mRNA technology last week. AZN has also submitted an application.
(more on my thread if of interest).

alphorn
Chat Pages: Latest  906  905  904  903  902  901  900  899  898  897  896  895  Older

Your Recent History

Delayed Upgrade Clock